Samuel Blackman

Samuel Blackman is a Senior Scientist at AstraZeneca, specializing in Biologics Engineering with a focus on protein engineering and novel modalities. They hold a PhD in Chemical Engineering from The University of Texas at Austin, where their research centers on antibody discovery and cancer biology. Their previous experiences include positions as a Visiting Graduate Researcher at UT Austin and volunteering at the US Environmental Protection Agency. Samuel has also garnered expertise through various research assistantships at North Carolina State University and the University of Colorado Boulder.